SpringWorks Therapeutics, Inc.
NASDAQ:SWTX
46.26 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -258.131 | -325.104 | -277.417 | -173.91 | -45.574 | -58.306 | -17.813 | -4.639 |
| Depreciation & Amortization
| 3.468 | 1.667 | 0.765 | 0.49 | 0.349 | 0.192 | 0.017 | 0.003 |
| Deferred Income Tax
| 0 | 0 | 0 | 0.988 | 0.605 | 0 | 0 | 0 |
| Stock Based Compensation
| 109.14 | 94.534 | 72.965 | 38.444 | 10.034 | 3.109 | 1.069 | 0 |
| Change In Working Capital
| -37.861 | -0.583 | 38.103 | 5.118 | 1.346 | 4.947 | 2.021 | 0.383 |
| Accounts Receivables
| -40.308 | -5.93 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -7.109 | -3.103 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 4.604 | -0.196 | 4.168 | 2.074 | -1.304 | 1.88 | 0.491 | 0.283 |
| Other Working Capital
| 4.952 | 8.646 | 33.935 | 3.044 | 2.65 | 3.067 | 1.53 | 0.1 |
| Other Non Cash Items
| 7.785 | 6.691 | 4.021 | 0.993 | 1.049 | 2.614 | 0.612 | 1.737 |
| Operating Cash Flow
| -175.599 | -222.795 | -161.563 | -127.877 | -32.191 | -47.444 | -14.706 | -2.239 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -4.451 | -7.385 | -10.196 | -2.016 | -0.642 | -0.67 | -0.293 | -0.044 |
| Acquisitions Net
| 0 | -2.8 | -4.2 | 2.016 | -3.5 | -3.59 | 0 | 0 |
| Purchases Of Investments
| -285.101 | -575.724 | -481.05 | -305.423 | -442.69 | -3.59 | 0 | 0 |
| Sales Maturities Of Investments
| 378.582 | 620.663 | 279.849 | 391.031 | 28 | 3.594 | 0 | 0 |
| Other Investing Activites
| -24.485 | 0 | -205.401 | -2.016 | -418.19 | -0.004 | 0 | 0 |
| Investing Cash Flow
| 64.545 | 34.754 | -215.597 | 83.592 | -418.832 | -4.26 | -0.293 | -0.044 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 299.3 | 340.066 | 1.157 | 269.592 | 169.73 | 50.376 | 12.554 |
| Common Stock Repurchased
| -8.438 | -2.8 | -1.341 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.763 | 0.278 | 1.977 | 1.157 | 0.893 | 163.978 | 50.376 | 12.554 |
| Financing Cash Flow
| 4.763 | 296.639 | 340.702 | 1.157 | 270.485 | 333.708 | 50.376 | 12.554 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -106.291 | 108.598 | -36.458 | -43.128 | -180.538 | 282.004 | 35.377 | 10.271 |
| Cash At End Of Period
| 70.375 | 176.666 | 68.068 | 104.526 | 147.654 | 328.192 | 45.648 | 10.271 |